NY A03693

Amends insurance law sections 3216, 3221, and 4303 to limit application of third-party prescription drug payment rules to specific drug categories: brand-name drugs without AB-rated generic equivalents, brand-name drugs with AB-rated generics that are accessible through prior authorization or insurer appeal processes, or generic drugs the insurer will cover.

Changes singular usage from "prescription drugs" to "prescription drug" in three insurance law provisions covering individual policies, group/blanket policies, and health service contracts.

Delays the effective date of prior 2022 legislation (S. 5299-A and A. 1741-A) from January to July following enactment for policies and contracts issued, renewed, modified, altered or amended on or after that date.

Maintains existing health savings account (HSA) compliance provisions under 26 USC 223, allowing third-party payments to count toward deductibles after minimum deductible satisfaction, with exceptions for preventive care services.